Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A mechanical reprogramming: synergistic tumor microenvironment normalization improves nano-immunotherapy delivery in prostate cancer via multiphysics modeling.

Drug delivery and translational research·2026
Same author

The Impact of Stenosis Severity on Hemodynamic Parameters in the Iliac Artery: A Fluid-Structure Interaction Study.

Bioengineering (Basel, Switzerland)·2025
Same author

Lessons Learned from Liver-on-Chip Platform.

Annals of biomedical engineering·2025
Same author

Mechanical Forces in Tumor Growth and Treatment: Perspectives From Biology, Physics, Engineering, and Mathematical Modeling.

WIREs mechanisms of disease·2025
Same author

CRISPR innovations in tissue engineering and gene editing.

Life sciences·2024
Same author

CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection.

Critical reviews in analytical chemistry·2024
Same journal

Therapeutic Applications and Advancements of Exosome-Based Treatments - A Comprehensive Review.

Current pharmaceutical biotechnology·2026
Same journal

Comparative Phytochemical Characterization and Antibacterial Activity of Ethanol and Aqueous Extracts of Moringa peregrina and Moringa oleifera against Multidrug-Resistant Bacteria.

Current pharmaceutical biotechnology·2026
Same journal

Unveiling Aptamers for Targeted Tumour Therapies and Detection: Systematic Evolution of Ligands by Exponential Enrichment (SELEX) Technology in Oncology.

Current pharmaceutical biotechnology·2026
Same journal

Nanosuspensions-Based Dry Powder Inhalers for Pulmonary Delivery of Hydrophobic Natural Products: Formulation Strategies, Efficacy, and Challenges.

Current pharmaceutical biotechnology·2026
Same journal

Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Accelerate Diabetic Rat Wound Healing by Inhibiting Pyroptosis through the NLRP3/Caspase-1/GSDMD Pathway.

Current pharmaceutical biotechnology·2026
Same journal

Cyperotundone Regulates Polo-like Kinase 1-mediated Glycolysis to Inhibit the Proliferation of Breast Cancer Cells.

Current pharmaceutical biotechnology·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Self-assembling peptides: potential role in tumor targeting.

Parisa Sadatmousavi1, Madjid Soltani, Reyhaneh Nazarian

  • 1Department of Chemical Engineering, University of Waterloo, Waterloo, Ontario, N2L 3G1, Canada.

Current Pharmaceutical Biotechnology
|April 8, 2011
PubMed
Summary
This summary is machine-generated.

This review explores self-assembling peptides (SAPs) and cell-targeting peptides (CTPs) for nanocarrier drug delivery systems. These peptides offer tunable structures and stimuli-responsiveness for enhanced therapeutic applications, particularly in cancer treatment.

More Related Videos

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix
10:23

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix
10:23

Fabrication and Characterization of Colorectal Cancer Organoids from SW1222 Cell Line in Ultrashort Self-Assembling Peptide Matrix

Published on: May 3, 2024

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Drug Delivery

Background:

  • Self-assembling peptides (SAPs) are versatile biomaterials with applications in various biomedical fields.
  • Cell-targeting peptides (CTPs) are crucial for directing therapeutic agents to specific sites.
  • Nanocarrier systems offer advanced platforms for drug delivery.

Purpose of the Study:

  • To review the design principles and properties of self-assembling peptides for nanocarrier development.
  • To discuss the role and identification methods of cancer-targeting peptides.
  • To explore the integration of SAPs and CTPs in advanced drug delivery systems.

Main Methods:

  • Review of existing literature on self-assembling peptides and cell-targeting peptides.
  • Analysis of peptide design principles, physical/chemical properties, and stimuli-responsiveness.
  • Discussion of combinatorial peptide library methods for identifying targeting peptides.

Main Results:

  • Self-assembling peptides form diverse nanostructures (e.g., peptide amphiphilies, bolaamphiphiles) with tunable properties.
  • These peptides exhibit stimuli-responsive behavior (pH, temperature, ionic strength).
  • Cancer-targeting peptides, like RGD, can be conjugated to nanocarriers to enhance tumor-specific delivery.

Conclusions:

  • SAPs and CTPs are key components in designing effective nanocarrier drug delivery systems.
  • The combination of SAPs' structural versatility and CTPs' targeting ability holds significant therapeutic potential.
  • Further research into peptide-based nanocarriers can advance targeted drug delivery, especially for cancer therapies.